These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Surfactant for respiratory distress syndrome: are there important clinical differences among preparations? Sinha S; Moya F; Donn SM Curr Opin Pediatr; 2007 Apr; 19(2):150-4. PubMed ID: 17496757 [TBL] [Abstract][Full Text] [Related]
25. Neonatal lung function in very immature infants with and without RDS. Kavvadia V; Greenough A; Itakura Y; Dimitriou G J Perinat Med; 1999; 27(5):382-7. PubMed ID: 10642959 [TBL] [Abstract][Full Text] [Related]
26. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy. Ho NK Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136 [TBL] [Abstract][Full Text] [Related]
28. [Pulmonary surfactant and the immune system]. Griese M Monatsschr Kinderheilkd; 1992 Jan; 140(1):57-61. PubMed ID: 1565109 [TBL] [Abstract][Full Text] [Related]
29. Expanded use of surfactant therapy in newborns. Lacaze-Masmonteil T Clin Perinatol; 2007 Mar; 34(1):179-89, ix. PubMed ID: 17394937 [TBL] [Abstract][Full Text] [Related]
30. Repeat surfactant therapy for postsurfactant slump. Katz LA; Klein JM J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122 [TBL] [Abstract][Full Text] [Related]
31. The development of surfactant replacement therapy and the various types of replacement surfactants. Shapiro DL Semin Perinatol; 1988 Jul; 12(3):174-9. PubMed ID: 3041602 [TBL] [Abstract][Full Text] [Related]
32. Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes. Carnielli VP; Zimmermann LJ; Hamvas A; Cogo PE J Perinatol; 2009 May; 29 Suppl 2():S29-37. PubMed ID: 19399007 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome. Ghaemi S; Mohamadymasodi M; Kelishadi R Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953 [TBL] [Abstract][Full Text] [Related]
34. Effects of recombinant Clara cell secretory protein (rhCC10) on inflammatory-related matrix metalloproteinase activity in a preterm lamb model of neonatal respiratory distress. Miller TL; Shashikant BN; Pilon AL; Pierce RA; Shaffer TH; Wolfson MR Pediatr Crit Care Med; 2007 Jan; 8(1):40-6. PubMed ID: 17149150 [TBL] [Abstract][Full Text] [Related]
36. Cost effectiveness of prevention and treatment of neonatal respiratory distress (RDS) with exogenous surfactant: what has changed in the last three decades? Mugford M Early Hum Dev; 2006 Feb; 82(2):105-15. PubMed ID: 16457971 [TBL] [Abstract][Full Text] [Related]
40. Animal-derived surfactants versus past and current synthetic surfactants: current status. Moya F; Maturana A Clin Perinatol; 2007 Mar; 34(1):145-77, viii. PubMed ID: 17394936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]